Moise
Moise Augis, Guadeloupe FR
Patent application number | Description | Published |
---|---|---|
20120251665 | SYSTEM AND METHOD FOR PREPARING A SHELF-STABLE BOTANICAL EXTRACT - A system and method for processing a plant material derived juice, comprising, substantially without a required pH modification, and substantially without a thermal antimicrobial process extracting a juice from plant material with a juice extractor, and filtering the juice through at least two tangential flow filter stages having a pore size of less than about 0.2 microns, to produce a substantially aseptic juice, which is substantially absent thermal decomposition products of sugars. | 10-04-2012 |
Moise Azria US
Patent application number | Description | Published |
---|---|---|
20150283212 | ORAL CALCITONIN COMPOSITIONS AND APPLICATIONS THEREOF - The present invention relates to compositions for the oral delivery of pharmacologically active calcitonin, to methods of synergistically enhancing the biological effects of orally administered calcitonin with D type vitamins and calcium, and to methods of treating and/or preventing disease in mammals, particularly humans, by orally administering calcitonin compositions in accordance with the invention. | 10-08-2015 |
Moise Bendayan, Saint-Laurent CA
Patent application number | Description | Published |
---|---|---|
20150132344 | Oral Leptin Formulations and Uses Thereof - An oral combination therapy or oral composition that protects orally administered exogenous leptin from the environment of the gastrointestinal tract, allowing delivery of the exogenous leptin to the bloodstream. The oral combination therapy includes (a) leptin or a leptin functional derivative; (b) a stomach acid-neutralizing agent such as a buffer; and (c) a pancreatic protease inhibitor that protects the exogenous leptin from degradation by pancreatic enzymes; and (d) a bile acid or a bile acid analog that facilitates absorption of the exogenous leptin. The oral combination therapy or oral composition may also include at least one agent that stimulates endogenous leptin secretion; as well as at least one agent capable of promoting, enhancing or improving adherence to treatment such as a sweetener or a satiety triggering agent. The oral combination therapy or oral composition can be a single composition in liquid or solid form, or can be administered simultaneously or sequentially so that the components mix in the stomach cavity of the patient. Methods and uses relating to the above oral combination therapy or oral composition to treat or prevent diseases of conditions that are associated with or can be ameliorated by leptin (e.g., obesity, weight gain, diabetes) are also included. | 05-14-2015 |
Moise Carcaud, Sainte Luce Sur Loire FR
Patent application number | Description | Published |
---|---|---|
20140055105 | VOLTAGE SCALING SYSTEM - A circuit for downscaling voltage comprising: a voltage regulator; a voltage reference register configured to provide a voltage reference value; a voltage comparator configured to output a logical one if a supply voltage of the voltage regulator is greater than the voltage reference value, wherein a first input of the voltage comparator is coupled to output of the voltage regulator and a second input of the voltage comparator is coupled to output of the voltage reference register; an AND gate, where a first input of the AND gate is coupled to output of the voltage comparator and a second input of the AND gate is coupled to a voltage reference ready signal; a switch configured to close based on output of logical one from the AND gate; and a pull-down resistor configured to couple to the output of the voltage regulator only if the switch is closed. | 02-27-2014 |